Nanjing Medical University First Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

1.Comparison of the Analgesic Effect of Remifentanil Group and Different Dose Groups of Oliceridine in Postoperative Patients Undergoing Cardiac Surgery 2.Exploring the Hemodynamic Effects of Analgesic Regimens With Different Doses of Oliceridine After Cardiac Surgery

Phase 4

Not yet recruiting

Conditions: Oliceridine
Postoperative Cardiac Surgery

Interventions: Drug: Low dose Oliceridine
Drug: High dose Oliceridine

First Posted Date: 2024-09-30

Last Posted Date: 2024-09-30

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 270

Registration Number: NCT06619145

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury

Active, not recruiting

Conditions: Myelinopathy

First Posted Date: 2024-09-23

Last Posted Date: 2024-09-23

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 100

Registration Number: NCT06608251

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).

Not yet recruiting

Conditions: Type1 Diabetes Mellitus

Interventions: Device: Continuous Glucose Monitoring System (GX-01S)

First Posted Date: 2024-09-23

Last Posted Date: 2024-09-23

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 1000

Registration Number: NCT06606509

Locations: 🇨🇳
Anqing Municipal Hospital, Anqing, Anhui, China
🇨🇳
The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China
🇨🇳
Hefei First People's Hospital, Hefei, Anhui, China

and more 98 locations

The Progress of Diabetes After Supaglutide Treatment in Type 2 Diabetes Patients

Recruiting

Conditions: Type 2 Diabetes Mellitus

First Posted Date: 2024-09-20

Last Posted Date: 2024-09-20

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 100

Registration Number: NCT06605287

Locations: 🇨🇳
Nanjing First Hospital, Nanjing Medical Univesity, Nanjing, China

Comparison of Remifentanil With a Combination of Remimazolam and Dexmedetomidine for Awake Tracheal Intubation

Not Applicable

Not yet recruiting

Conditions: Difficult or Failed Intubation
Sedative Adverse Reaction

Interventions: Drug: remimazolam combined with remifentanil
Drug: dexmedetomidine combined with remifentanil

First Posted Date: 2024-09-03

Last Posted Date: 2024-09-03

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 60

Registration Number: NCT06581731

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With Depression

Not Applicable

Not yet recruiting

Conditions: Functional Dyspepsia
Depression

Interventions: Drug: zuojinwan
Drug: Rabeprazole sodium enteric-coated tablets
Drug: mosapride citrate

First Posted Date: 2024-07-01

Last Posted Date: 2024-07-01

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 120

Registration Number: NCT06481371

Zuojin Wan Combined With Woonosan Fumarate for the Treatment of GRD Combined With Depression

Not Applicable

Not yet recruiting

Conditions: Gastroesophageal Reflux Disease
Depression

Interventions: Drug: Vonorasan Fumarate
Drug: Zuojin Pills

First Posted Date: 2024-07-01

Last Posted Date: 2024-07-01

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 300

Registration Number: NCT06481787

Risk Assessment of Proximal Contact Loss Between Implant-supported Prostheses and Adjacent Teeth.

Not yet recruiting

Conditions: Peri-Implantitis and Peri-implant Mucositis

First Posted Date: 2024-06-26

Last Posted Date: 2024-06-26

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 100

Registration Number: NCT06475313

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Implementing the Wuqinxi on Patients With Pulmonary Arterial Hypertension

Not Applicable

Not yet recruiting

Conditions: Pulmonary Arterial Hypertension PAH

Interventions: Other: wu qinxi

First Posted Date: 2024-06-12

Last Posted Date: 2024-06-12

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 60

Registration Number: NCT06454422

Patients' Positions on Analgesic Efficacy of ESPB

Not Applicable

Recruiting

Conditions: Erector Spinae Plane Block

Interventions: Procedure: position

First Posted Date: 2024-06-04

Last Posted Date: 2025-04-03

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 156

Registration Number: NCT06441071

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Home Terms & Conditions Privacy Policy